本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Organogenesis Holdings Inc

5.01
-0.2400-4.57%
盤後5.020.0100+0.20%19:59 EDT
成交量:103.93萬
成交額:531.73萬
市值:6.35億
市盈率:-501.00
高:5.40
開:5.26
低:4.99
收:5.25
資料載入中...

公司資料

公司名字:
Organogenesis Holdings Inc
交易所:
NASDAQ
成立時間:
- -
員工人數:
869
公司地址:
85 Dan Road,Canton,Massachusetts,United States
郵編:
02021
電話:
傳真:
- -
簡介:
Organogenesis Holdings Inc.是特拉華州的一家公司。該公司是一家領先的再生醫學公司,在先進的傷口護理和外科生物製劑(包括骨科和脊柱)中提供生物活性和非細胞生物材料產品組合。Organogenesis全面的產品組合旨在治療各種有修復和再生需求的患者。

董事

名稱
職位
Gary S. Gillheeney, Sr.
Director, Chairman of the Board, President and Chief Executive Officer
Arthur S. Leibowitz
Director, Lead Independent Director
Alan A. Ades
Director
David Erani
Director
Gilberto Quintero
Director
Glenn H. Nussdorf
Director
Jon Giacomin
Director
Michael J. Driscoll
Director
Michele Korfin
Director
Prathyusha Duraibabu
Director
Robert Ades
Director

股東

名稱
職位
Gary S. Gillheeney, Sr.
Director, Chairman of the Board, President and Chief Executive Officer
Patrick Bilbo
Chief Operating Officer
David C. Francisco
Chief Financial Officer
Antonio S. Montecalvo
Vice President, Health Policy
Brian Grow
Chief Commercial Officer
Lori Freedman
Chief Administrative and Legal Officer